Chinese researchers have identified a potential gene-editing target for the treatment of cardiomyocyte hypertrophy (increased cardiac muscle mass) in early childhood. The gene Myh7 was identified in a mouse model using CASAAV - a CRISPR based platform for rapid dissection of gene function in vivo - and its inhibition led to a reversal of the disease.
Electroporation is sometimes used for delivering gene-editing machinery to target cells, but most commercial electroporation machimes are not suited for large-scale, automated use. Now, American researchers have developed a microfluidic continuous-flow electrotransfection device that was demonstrated to deliver mRNA into 500 million T-cells at a rate of 20 million cells/min.
Rubius Therapeutics has presented preclinical data for RTX-321, a red cell therapeutic oncology product candidate for HPV-positive cancers. The data demonstrate that RTX-321 has a dual mechanism of action by not only functioning as an antigen-presenting cell to boost HPV 16 antigen-specific T cell responses but also promoting broad immune system stimulation of both innate and adaptive immunity.
You already know cane sugar and beet sugar - but here comes rice sugar. Chinese researchers knocked-out the GCS1 gene in rice using CRISPR technology and found that the resulting rice plants had ovules (seed progenitors) containing 10-20% high-quality sucrose. The researchers suggest that this can pave the way for developing new sugar-producing crops suitable for diverse ecological zones.
A 100% female-to-male sex conversion in Drosophila fruitflies has been achieved using CRISPR/Cas9 HDR-induced point mutations in the sex determination gene tra2. The German researchers suggest that their achievement can eventually be used in eradication of insect pests like mosquitos.